F. Rodriguez et al., DEXAMETHASONE INDUCES ALTERED BINDING OF REGULATORY FACTORS TO HLA CLASS-I ENHANCER SEQUENCE IN MCF-7 BREAST-TUMOR CELL-LINE, Cancer immunology and immunotherapy, 46(4), 1998, pp. 194-200
Several reports have shown the importance of MHC class I antigens in e
nabling the host to regulate tumour growth in vivo, Glucocorticoid hor
mones have strong immunosuppressive effects and are known regulators o
f gene transcription. In this work we studied the expression of major
histocompatibility complex (MHC) class I antigens in three breast carc
inoma cell lines before and after treatment with the synthetic glucoco
rticoid dexamethasone. HLA class I expression in the cell line MCF-7 w
as downregulated in the presence of dexamethasone. This down modulatio
n of expression appeared to be mediated by transcriptional mechanisms,
as revealed by HLA class I mRNA levels. To elucidate the basis of MHC
class I downregulation by dexamethasone, we examined transcriptional
factor-binding activity to the HLA class I regulatory element or enhan
cer A by electrophoretic-mobility-shift assays, using synthesized olig
onucleotides corresponding to upstream conserved sequences of MHC clas
s I genes. Our results showed that dexamethasone induced a different b
inding to the MHC class I regulatory elements in the MCF-7 cell line f
rom that of the other cell lines included in our study. MCF-7 cells pr
esented a strong decrease in previous factor-binding activity to the C
RE II probe (H2-RIIBP-like binding activity) and a new factor-binding
activity was apparent. On the other hand, CRE I region showed an incre
ase in KBF1-factor-binding activity. These results suggest that glucoc
orticoids down-modulate the expression of MHC class I antigens by alte
ring the binding to the enhancer A sequence. In addition, this down-mo
dulation may affect the regulation of tumour growth by the host's immu
ne system.